Susquehanna International Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $571K | Buy |
162,800
+110,000
| +208% | +$451K | ﹤0.01% | 9321 |
|
|
2025
Q4 | $178K | Buy |
+52,800
| New | +$137K | ﹤0.01% | 11011 |
|
|
2024
Q3 | – | Sell |
-27,500
| Closed | -$179K | – | 12482 |
|
|
2024
Q2 | $179K | Sell |
27,500
-197,800
| -88% | -$1.4M | ﹤0.01% | 10512 |
|
|
2024
Q1 | $1.96M | Sell |
225,300
-142,500
| -39% | -$1.73M | ﹤0.01% | 5392 |
|
|
2023
Q4 | $4.21M | Buy |
367,800
+328,000
| +824% | +$3.24M | ﹤0.01% | 4008 |
|
|
2023
Q3 | $383K | Buy |
39,800
+3,900
| +11% | +$38.2K | ﹤0.01% | 8830 |
|
|
2023
Q2 | $382K | Buy |
35,900
+6,300
| +21% | +$67.7K | ﹤0.01% | 8941 |
|
|
2023
Q1 | $311K | Buy |
29,600
+16,700
| +129% | +$187K | ﹤0.01% | 9638 |
|
|
2022
Q4 | $160K | Buy |
+12,900
| New | +$146K | ﹤0.01% | 10418 |
|
|
2022
Q1 | – | Sell |
-221,700
| Closed | -$2.58M | – | 13482 |
|
|
2021
Q4 | $2.58M | Sell |
221,700
-25,200
| -10% | -$309K | ﹤0.01% | 4934 |
|
|
2021
Q3 | $3.23M | Sell |
246,900
-4,200
| -2% | -$54.3K | ﹤0.01% | 4802 |
|
|
2021
Q2 | $3.23M | Sell |
251,100
-5,200
| -2% | -$59.5K | ﹤0.01% | 4854 |
|
|
2021
Q1 | $2.87M | Sell |
256,300
-666,600
| -72% | -$7.04M | ﹤0.01% | 5073 |
|
|
2020
Q4 | $10.5M | Buy |
922,900
+70,400
| +8% | +$770K | ﹤0.01% | 2435 |
|
|
2020
Q3 | $7.67M | Buy |
852,500
+214,400
| +34% | +$2.13M | ﹤0.01% | 2521 |
|
|
2020
Q2 | $6.58M | Buy |
638,100
+10,700
| +2% | +$110K | ﹤0.01% | 2649 |
|
|
2020
Q1 | $6.33M | Sell |
627,400
-11,600
| -2% | -$136K | ﹤0.01% | 2283 |
|
|
2019
Q4 | $8.51M | Sell |
639,000
-97,900
| -13% | -$1.08M | ﹤0.01% | 2268 |
|
|
2019
Q3 | $6.33M | Buy |
736,900
+112,400
| +18% | +$1.09M | ﹤0.01% | 2438 |
|
|
2019
Q2 | $6.83M | Buy |
624,500
+193,227
| +45% | +$2.16M | ﹤0.01% | 2325 |
|
|
2019
Q1 | $4.89M | Buy |
431,273
+64,357
| +18% | +$719K | ﹤0.01% | 2490 |
|
|
2018
Q4 | $3.18M | Buy |
366,916
+77,013
| +27% | +$884K | ﹤0.01% | 2857 |
|
|
2018
Q3 | $4.48M | Sell |
289,903
-75,342
| -21% | -$1.19M | ﹤0.01% | 2823 |
|
|
2018
Q2 | $5.85M | Buy |
365,245
+296,471
| +431% | +$4.39M | ﹤0.01% | 2521 |
|
|
2018
Q1 | $889K | Buy |
68,774
+27,342
| +66% | +$341K | ﹤0.01% | 5506 |
|
|
2017
Q4 | $520K | Sell |
41,432
-125,489
| -75% | -$1.64M | ﹤0.01% | 6562 |
|
|
2017
Q3 | $2.21M | Buy |
166,921
+82,386
| +97% | +$1.13M | ﹤0.01% | 3731 |
|
|
2017
Q2 | $1.34M | Sell |
84,535
-61,014
| -42% | -$887K | ﹤0.01% | 4663 |
|
|
2017
Q1 | $2.08M | Sell |
145,549
-3,820
| -3% | -$52.2K | ﹤0.01% | 3658 |
|
|
2016
Q4 | $1.91M | Buy |
149,369
+46,327
| +45% | +$585K | ﹤0.01% | 4159 |
|
|
2016
Q3 | $1.37M | Sell |
103,042
-59,820
| -37% | -$699K | ﹤0.01% | 4214 |
|
|
2016
Q2 | $1.78M | Buy |
162,862
+43,104
| +36% | +$421K | ﹤0.01% | 3772 |
|
|
2016
Q1 | $1.1M | Buy |
119,758
+47,640
| +66% | +$393K | ﹤0.01% | 4899 |
|
|
2015
Q4 | $700K | Buy |
72,118
+3,821
| +6% | +$36.9K | ﹤0.01% | 6142 |
|
|
2015
Q3 | $596K | Sell |
68,297
-225,666
| -77% | -$2.11M | ﹤0.01% | 6774 |
|
|
2015
Q2 | $2.97M | Buy |
293,963
+30,925
| +12% | +$359K | ﹤0.01% | 3872 |
|
|
2015
Q1 | $3.52M | Buy |
263,038
+197,487
| +301% | +$2.59M | ﹤0.01% | 3267 |
|
|
2014
Q4 | $841K | Sell |
65,551
-59,222
| -47% | -$678K | ﹤0.01% | 6198 |
|
|
2014
Q3 | $1.35M | Sell |
124,773
-59,939
| -32% | -$686K | ﹤0.01% | 5329 |
|
|
2014
Q2 | $2.37M | Sell |
184,712
-34,984
| -16% | -$380K | ﹤0.01% | 4333 |
|
|
2014
Q1 | $2.27M | Sell |
219,696
-131,459
| -37% | -$1.48M | ﹤0.01% | 4122 |
|
|
2013
Q4 | $3.41M | Buy |
351,155
+150,921
| +75% | +$1.35M | ﹤0.01% | 3473 |
|
|
2013
Q3 | $1.99M | Buy |
200,234
+42,148
| +27% | +$413K | ﹤0.01% | 4112 |
|
|
2013
Q2 | $1.32M | Buy |
+158,086
| New | +$1.92M | ﹤0.01% | 4553 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Susquehanna International Group's IRWD Position: Q1 2026 in Review
Susquehanna International Group increased its Ironwood Pharmaceuticals (IRWD) stake by 228% in Q1 2026, buying an estimated $4.19M and bringing the position to 1,472,157 shares worth $5.17M. The position accounts for ﹤0.01% of the portfolio, ranked #4159.
Susquehanna International Group first reported a position in IRWD in Q3 2013 and has held it in 43 quarters since. The position peaked at $7.01M in Q1 2015. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Susquehanna International Group held 1,472,157 shares of Ironwood Pharmaceuticals worth $5.17M as of Q1 2026.
- Susquehanna International Group bought 1,023,358 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $4.19M.
- Ironwood Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4159 holding.
- Susquehanna International Group first reported a position in Ironwood Pharmaceuticals in Q3 2013 and has held it in 43 quarters since.
- Susquehanna International Group's Ironwood Pharmaceuticals position peaked at $7.01M in Q1 2015.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.